Yes. I was in the 30% group of patients that would not show a response to BCG per Valar Lab’s Vesta Bladder BCGPredict. I had just started my BCG induction instillations, and discussed whether I should continue the 6-week course or switch to chemotherapy. I asked his personal opinion, and he recommended continuing with the BCG course as data analysis was prospective and there is low risk of disease progression. Another oncologist didn’t give much weight to this test (perhaps he was a little old school, but he may not have felt it was ready for prime time). Did you get a ‘no response to BCG’ result?